News

The approval is supported by a study involving 453 adults with advanced platinum-resistant cancers of the ovary, fallopian ...
First of all, only 10 percent of the research budget at the NIH goes to women’s health. One review found five times more ...
Cancer diagnosis in young people is on the rise, but there are practical ways to support loved ones going through treatment.
AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency ...
"The doctor got mad about it and yelled at the PA about wasting resources in front of my friend. When the results came back, ...
My mum was so young when I lost her to breast cancer. She was only 35. I was eight and my sister Charlotte was nine. Sixteen ...
Doctors in Uttar Pradesh's Bulandshahr were taken aback when an MRI scan of a 30-year-old woman revealed that the foetus was ...
In an emotional segment on Giovanna Fletcher's Happy Mum, Happy Baby podcast, Anton opened up about their path to becoming ...
DelveInsight’s Advanced Ovarian Cancer pipeline report depicts a robust space with 50+ active players working to develop 50+ ...
AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibody-drug conjugate (ADC ...
A woman who struggled to recover from a bout of food poisoning after her Christmas work do went on to be diagnosed with a ...
The singer said it is a bittersweet diagnosis and although sad, she feels validated after thinking the pain was in her head ...